The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Hookipa Biotech; Incyte; Merck Serono
Liquid biopsy for diagnosis in patients with suspected pancreatic and biliary tract cancers: PREVAIL ctDNA pilot trial.
 
Justin Mencel
No Relationships to Disclose
 
Andrew Feber
No Relationships to Disclose
 
Ruwaida Begum
No Relationships to Disclose
 
Paul Carter
No Relationships to Disclose
 
Michaela Smalley
No Relationships to Disclose
 
Elli Bourmpaki
No Relationships to Disclose
 
Josh Shur
No Relationships to Disclose
 
Sameer Zar
No Relationships to Disclose
 
Darina Kohoutova
No Relationships to Disclose
 
Sanjay Popat
Honoraria - Amgen; AstraZeneca; Bayer; BeiGene; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Guardant Health; Guardant Health; Incyte; Janssen; Lilly; Merck KGaA; MSD; Novartis; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BeiGene; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Guardant Health; Incyte; Janssen; Lilly; Merck KGaA; MSD; Novartis; Pfizer; Roche; Takeda
Research Funding - ARIAD (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Guardant Health (Inst); Janssen (Inst); Lilly (Inst); Mirati Therapeutics; MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst); Trizell; Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Merck Sharp & Dohme; Roche
 
Angela George
Honoraria - amgen; Astez; AstraZeneca; Bayer; Bristol Myers Squibb Foundation; Incyte; Merck; Novartis; Qiagen
Consulting or Advisory Role - AstraZeneca; Guardant Health; Illumina; Lilly; Roche
 
Terri Patricia McVeigh
Honoraria - AstraZeneca; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Roche
 
Michael Hubank
Honoraria - Boehringer Ingelheim; Incyte (Inst); Qiagen
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol Myers Squibb Foundation; Guardant Health; Illumina; Lilly; Roche
 
Clare Peckitt
No Relationships to Disclose
 
Charlotte Victoria Fribbens
No Relationships to Disclose
 
David J. Watkins
No Relationships to Disclose
 
Sheela Rao
No Relationships to Disclose
 
Ian Chau
Honoraria - Eisai; Lilly; SERVIER
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD Oncology; OncXerna Therapeutics; Pierre Fabre; Roche/Genentech; Sotio
Research Funding - Janssen-Cilag (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; MSD
 
David Cunningham
Stock and Other Ownership Interests - OVIBIO
Consulting or Advisory Role - OVIBIO
Research Funding - 4SC (Inst); Bayer (Inst); Celgene (Inst); Clovis Oncology (Inst); Leap Oncology (Inst); Lilly (Inst); MedImmune (Inst); Roche (Inst)
 
Naureen Starling
Honoraria - Amgen; GlaxoSmithKline; Lilly; Merck Serono; MSD Oncology; Pierre Fabre; SERVIER
Consulting or Advisory Role - AstraZeneca; MSD; Pfizer; SERVIER
Research Funding - AstraZeneca (Inst); BMS (Inst); Pfizer/EMD Serono (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS; Lilly; Merck; MSD Oncology; Roche